Peptide dendrimers are a novel class of macromolecules of emerging interest with the potential of delayed renal clearance due to their molecular size and enhanced activity due to the multivalency effect. Difficulties in the synthesis of homogeneous dendrimers carrying wellstructured peptides have largely hampered progress in this field. In this work, an active analogue of the disulfide rich chi-conotoxin χ-MrIA, a norepinephrine reuptake (NET) inhibitor, was grafted onto a polylysine dendron. Dendron decoration was achieved by employing copper catalyzed alkyne-azide cycloaddition (CuAAc) in combination with the use of hydrophilic PEG linkers, leading to homogenous 4-and 8-mer χ-MrIA dendrimers with molecular weights from 8 KDa to 22 KDa. These dendrimers were investigated for their impact on peptide secondary structure, in vitro functional activity and potential anti-allodynia function in vivo. NMR studies showed that the χ-MrIA-peptide analogue tertiary structure was identical to the parent peptide in the two dendrimers. In a functional norepinephrine transporter reuptake assay, χ-MrIA dendrimers showed slightly increased potency relative to the azido-PEGylated χ-MrIA analogues but no improvement compared to the parent peptide χ-MrIA. In contrast to χ-MrIA, no antiallodynic action was observed when χ-MrIA dendrimers were administered intrathecally in a rat model of neuropathic pain, suggesting that the larger dendrimer structure is unable to diffuse through spinal column tissue to reach the NET transporter.